These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 22522615

  • 1. Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes.
    Sung JY, Park SB, Liu YT, Kwai N, Arnold R, Krishnan AV, Lin CS.
    Diabetes; 2012 Jun; 61(6):1592-8. PubMed ID: 22522615
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy.
    Krishnan AV, Lin CS, Kiernan MC.
    Brain; 2008 May; 131(Pt 5):1209-16. PubMed ID: 18362098
    [Abstract] [Full Text] [Related]

  • 6. Correlation between markers of peripheral nerve function and structure in type 1 diabetes.
    Borire AA, Issar T, Kwai NC, Visser LH, Simon NG, Poynten AM, Kiernan MC, Krishnan AV.
    Diabetes Metab Res Rev; 2018 Oct; 34(7):e3028. PubMed ID: 29858541
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In Vivo.
    Kwai NC, Nigole W, Poynten AM, Brown C, Krishnan AV.
    PLoS One; 2016 Oct; 11(4):e0153389. PubMed ID: 27078166
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes.
    Kwai NCG, Arnold R, Poynten AM, Howells J, Kiernan MC, Lin CS, Krishnan AV.
    Clin Neurophysiol; 2016 Feb; 127(2):1700-1706. PubMed ID: 26725257
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Peripheral nerve excitability measures at different target levels: the effects of aging and diabetic neuropathy.
    Shibuta Y, Nodera H, Mori A, Okita T, Kaji R.
    J Clin Neurophysiol; 2010 Oct; 27(5):350-7. PubMed ID: 20844439
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.
    Park SB, Lin CS, Krishnan AV, Goldstein D, Friedlander ML, Kiernan MC.
    Brain; 2009 Oct; 132(Pt 10):2712-23. PubMed ID: 19745023
    [Abstract] [Full Text] [Related]

  • 18. Tibial nerve axonal excitability in type 1 diabetes mellitus.
    Gencpinar P, Çelmeli G, Duman Ö, Haspolat Ş, Uysal H.
    Muscle Nerve; 2019 Jan; 59(1):76-81. PubMed ID: 30019351
    [Abstract] [Full Text] [Related]

  • 19. Evolution of peripheral nerve function in humans: novel insights from motor nerve excitability.
    Farrar MA, Park SB, Lin CS, Kiernan MC.
    J Physiol; 2013 Jan 01; 591(1):273-86. PubMed ID: 23006483
    [Abstract] [Full Text] [Related]

  • 20. Dysfunction of axonal membrane conductances in adolescents and young adults with spinal muscular atrophy.
    Farrar MA, Vucic S, Lin CS, Park SB, Johnston HM, du Sart D, Bostock H, Kiernan MC.
    Brain; 2011 Nov 01; 134(Pt 11):3185-97. PubMed ID: 21926101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.